Increase use of β-blockers in patients with chronic obstructive pulmonary and cardiovascular disease

Eur Heart J. 2021 Mar 21;42(12):1181. doi: 10.1093/eurheartj/ehab005.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Cardiovascular Diseases* / epidemiology
  • Humans
  • Lung

Substances

  • Adrenergic beta-Antagonists